Baird Downgrades Tandem Diabetes Care (TNDM) to Neutral
- Wall St lackluster ahead of Easter break, eyes sharp Q1 gains
- Home Depot agrees to buy SRS Distribution, sees TAM expanding to $1 trillion
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- Stocks flat as strong quarter nears end; yen on intervention watch
- Dollar gains on euro with Fed's Waller hawkish on rates
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- Discover Financial Services (DFS) Announces CEO Resignation
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Timken (TKR) Appoints Tarak Mehta as New CEO
Feltl & Co Downgrades Tandem Diabetes Care (TNDM) to Buy
November 2, 2016 10:52 AM EDTFeltl & Co downgraded Tandem Diabetes Care (NASDAQ: TNDM) from Strong Buy to Buy.
For an analyst ratings summary and ratings history on Tandem Diabetes Care click here. For more ratings news on Tandem Diabetes Care click here.
Shares of Tandem Diabetes Care closed at $5.35 yesterday.
... MoreUPDATE: Stifel Downgrades Tandem Diabetes Care (TNDM) to Hold
November 2, 2016 7:22 AM EDT(Updated - November 2, 2016 10:59 AM EDT)
Stifel downgraded Tandem Diabetes Care (NASDAQ: TNDM) from Buy to Hold with a price target of $3.50 (from $15.00).
Analyst Rick Wise commented on the rating change, saying, "We are downgrading TNDM shares to Hold from Buy following a... More